サンプル依頼リスト カート
  • English
  • Korean
表紙：臓器移植拒絶反応抑制薬の世界市場規模調査・予測：薬剤クラス別、移植タイプ別、流通チャネル別、地域別分析、2023-2030年
市場調査レポート
商品コード
1381812

臓器移植拒絶反応抑制薬の世界市場規模調査・予測：薬剤クラス別、移植タイプ別、流通チャネル別、地域別分析、2023-2030年

Global Organ Transplant Rejection Medication Market Size study & Forecast, by Drug Class, by Transplant Type, by Distribution Channel, and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
臓器移植拒絶反応抑制薬の世界市場規模調査・予測：薬剤クラス別、移植タイプ別、流通チャネル別、地域別分析、2023-2030年
出版日: 2023年10月20日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の臓器移植拒絶反応抑制薬市場は、2022年には約49億米ドルと評価され、予測期間2023-2030年には3.9％以上の成長率で成長すると予測されています。

臓器移植は、組織や臓器をある人の体から別の人の体に移植する外科手術です。臓器移植拒絶反応抑制薬は、移植を受けた患者の臓器拒絶反応を予防するために使用されます。慢性疾患の罹患率の上昇と臓器不全の発生率の増加が、予測期間中の臓器移植拒絶反応抑制薬市場の成長をもたらす主な要因です。

保健資源サービス庁によると2022年、米国では42,887件以上の臓器移植が実施され、2021年比で3.7%増加しました。また、保健社会福祉省によると、2023年3月には、世界中で約10万4234人の患者が臓器移植を待っています。このように、慢性疾患の罹患率の上昇と臓器不全の発生率の増加が、全世界の市場需要を煽っています。また、新しい手術技術や免疫抑制剤などの技術の進歩、臓器提供者数の増加が市場の成長を加速させています。さらに、高齢化社会における臓器移植の利点に関する意識の高まりや、研究開発資金の増加は、市場に有利な成長機会をもたらすと予想されます。しかし、高額な費用と複雑な手順が、2023-2030年の予測期間を通じて市場の成長を阻害しています。

臓器移植拒絶反応抑制薬の世界市場調査において考慮された主要地域には、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカが含まれます。北米は、慢性疾患の罹患率の上昇、有利な償還政策、技術の進歩、高度な医療インフラの存在などの要因により、収益面で市場を独占しています。アジア太平洋地域は、慢性疾患の罹患率の増加、医療費の増加、経済的な余裕の増加、臓器移植拒絶反応抑制薬に対する意識の高まりにより、最も急成長している地域です。

本調査の目的は、近年における様々なセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における業界の質的・量的側面を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 世界の臓器移植拒絶反応抑制薬市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 業界の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 世界の臓器移植拒絶反応抑制薬市場力学

  • 臓器移植拒絶反応抑制薬市場の影響分析（2020-2030年）
    • 市場促進要因
      • 慢性疾患の増加
      • 臓器不全の発生率の増加
    • 市場の課題
      • 薬価の高騰
      • 臓器移植の複雑な手順
    • 市場機会
      • 臓器移植の利点に関する意識の高まり
      • 研究開発資金の増加

第4章 世界の臓器移植拒絶反応抑制薬市場：産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治的
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 臓器移植拒絶反応抑制薬の世界市場：薬剤クラス別

  • 市場スナップショット
  • 臓器移植拒絶反応抑制薬の世界市場：薬剤クラス別、実績 - ポテンシャル分析
  • 臓器移植拒絶反応抑制薬の世界市場：薬剤クラス別推定・予測、2020-2030年
  • 臓器移植拒絶反応抑制薬の世界市場、サブセグメント別分析
    • 抗体
    • 代謝拮抗薬
    • カルシニューリン阻害薬
    • mTOR阻害薬
    • ステロイド

第6章 臓器移植拒絶反応抑制薬の世界市場：移植タイプ別

  • 市場スナップショット
  • 臓器移植拒絶反応抑制薬の世界市場：移植タイプ別、実績 - ポテンシャル分析
  • 臓器移植拒絶反応抑制薬の世界市場：移植タイプ別推定・予測、2020-2030年
  • 臓器移植拒絶反応抑制薬の世界市場、サブセグメント別分析
    • 腎臓
    • 肝臓
    • 心臓
    • 肺
    • 膵臓
    • その他

第7章 臓器移植拒絶反応抑制薬の世界市場：流通チャネル別

  • 市場スナップショット
  • 臓器移植拒絶反応抑制薬の世界市場：流通チャネル別実績 - ポテンシャル分析
  • 臓器移植拒絶反応抑制薬の世界市場：流通チャネル別推定・予測、2020-2030年
  • 臓器移植拒絶反応抑制薬市場のサブセグメント分析
    • 病院薬局
    • 小売薬局
    • オンライン薬局

第8章 臓器移植拒絶反応抑制薬の世界市場：地域別分析

  • 主要国
  • 主な新興国
  • 臓器移植拒絶反応抑制薬市場、地域別市場スナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州の臓器移植拒絶反応抑制薬市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋の臓器移植拒絶反応抑制薬市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの臓器移植拒絶反応抑制薬市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Pfizer, Inc.
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • Astellas Pharma Global Development, Inc.
    • F, Hoffmann-La Roche Ltd.
    • Bristol-Myers Squibb Company
    • GlaxoSmithKline plc.
    • AbbVie Inc.
    • Viatris, Inc.
    • Hikma Pharmaceuticals plc.
    • Teva Pharmaceutical Industries Ltd,
    • Cadila Healthcare Limited

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Organ Transplant Rejection Medication Market, report scope
  • TABLE 2. Global Organ Transplant Rejection Medication Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Organ Transplant Rejection Medication Market estimates & forecasts by Drug Class 2020-2030 (USD Billion)
  • TABLE 4. Global Organ Transplant Rejection Medication Market estimates & forecasts by Transplant Type 2020-2030 (USD Billion)
  • TABLE 5. Global Organ Transplant Rejection Medication Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
  • TABLE 6. Global Organ Transplant Rejection Medication Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Organ Transplant Rejection Medication Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Organ Transplant Rejection Medication Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Organ Transplant Rejection Medication Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Organ Transplant Rejection Medication Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Organ Transplant Rejection Medication Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Organ Transplant Rejection Medication Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Organ Transplant Rejection Medication Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Organ Transplant Rejection Medication Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Organ Transplant Rejection Medication Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Organ Transplant Rejection Medication Market
  • TABLE 71. List of primary sources, used in the study of global Organ Transplant Rejection Medication Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Organ Transplant Rejection Medication Market, research methodology
  • FIG 2. Global Organ Transplant Rejection Medication Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Organ Transplant Rejection Medication Market, key trends 2022
  • FIG 5. Global Organ Transplant Rejection Medication Market, growth prospects 2023-2030
  • FIG 6. Global Organ Transplant Rejection Medication Market, porters 5 force model
  • FIG 7. Global Organ Transplant Rejection Medication Market, pest analysis
  • FIG 8. Global Organ Transplant Rejection Medication Market, value chain analysis
  • FIG 9. Global Organ Transplant Rejection Medication Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Organ Transplant Rejection Medication Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Organ Transplant Rejection Medication Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Organ Transplant Rejection Medication Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Organ Transplant Rejection Medication Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Organ Transplant Rejection Medication Market, regional snapshot 2020 & 2030
  • FIG 15. North America Organ Transplant Rejection Medication Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Organ Transplant Rejection Medication Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Organ Transplant Rejection Medication Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Organ Transplant Rejection Medication Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Organ Transplant Rejection Medication Market 2020 & 2030 (USD Billion)

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

目次

Global Organ Transplant Rejection Medication Market is valued at approximately USD 4.9 billion in 2022 and is anticipated to grow with a growth rate of more than 3.9% over the forecast period 2023-2030. Organ transplantation is a surgical procedure in which tissue, or an organ is transferred from one person's body to another person's body. Organ transplant rejection medication is used to prevent organ rejection in transplant recipients. The rising incidence of chronic disease and the increased incidence of organ failure are the key factors responsible for the market growth of the Organ Transplant Rejection Medication Market over the forecast period.

According to the Health Resources and Services Administration. In 2022, in the U.S., more than 42,887 organ transplants were performed and it's an increase of 3.7% over 2021. Also, according to the Department of Health & Human Services, in Mar 2023, approximately 104,234 patients across the globe were waiting to receive organs for transplant. Thus, the rising incidence of chronic disease and the increased incidence of organ failure are fueling the market demand across the globe. Also, advancements in technology, such as new surgical techniques and immunosuppressive drugs and a rise in the number of organ donors accelerate market growth. Moreover, increased awareness about the benefits of organ transplantation in an aging population and an increase in funding for research and development are anticipated to create lucrative growth opportunities for the market. However, the high cost and complex procedures stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Organ Transplant Rejection Medication Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in terms of revenue owing to factors such as the rising incidence of chronic disease, favorable reimbursement policies, technological advancement and the presence of advanced healthcare infrastructure create market growth in this region. Asia-Pacific is the fastest-growing region due to increasing incidence of chronic diseases, rising healthcare expenditure, rise in affordability and increased awareness about organ rejection medications in the region.

Major market player included in this report are:

  • Pfizer, Inc.
  • Astellas Pharma Global Development, Inc.
  • F, Hoffmann-La Roche Ltd.
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc.
  • AbbVie Inc.
  • Viatris, Inc.
  • Hikma Pharmaceuticals plc.
  • Teva Pharmaceutical Industries Ltd
  • Cadila Healthcare Limited

Recent Developments in the Market:

  • In August 2022, Strides gained USFDA certification for their Cyclosporine Softgel Capsule. Strides strengthened its market position by adding Cyclosporine Softgel capsules, Tacrolimus capsules and an immunosuppressive medicine line for the US market.

Global Organ Transplant Rejection Medication Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Drug Class, Transplant Type, Distribution channel, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:

  • Antibodies
  • Antimetabolites
  • Calcineurin Inhibitors
  • mTOR Inhibitors
  • Steroids

By Transplant Type:

  • Kidney
  • Liver
  • Heart
  • Lung
  • Pancreas
  • Others

By Distribution Channel:

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Organ Transplant Rejection Medication Market, by region, 2020-2030 (USD Billion)
    • 1.2.2. Organ Transplant Rejection Medication Market, by Drug Class, 2020-2030 (USD Billion)
    • 1.2.3. Organ Transplant Rejection Medication Market, by Transplant Type, 2020-2030 (USD Billion)
    • 1.2.4. Organ Transplant Rejection Medication Market, by Distribution Channel, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Organ Transplant Rejection Medication Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Organ Transplant Rejection Medication Market Dynamics

  • 3.1. Organ Transplant Rejection Medication Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising incidence of chronic disease
      • 3.1.1.2. Increased incidence of organ failure
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of medication
      • 3.1.2.2. Complex procedures of organ transplant
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increased awareness about the benefits of organ transplantation
      • 3.1.3.2. Increase in funding for research and development

Chapter 4. Global Organ Transplant Rejection Medication Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economic
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Organ Transplant Rejection Medication Market, by Drug Class

  • 5.1. Market Snapshot
  • 5.2. Global Organ Transplant Rejection Medication Market by Drug Class, Performance - Potential Analysis
  • 5.3. Global Organ Transplant Rejection Medication Market Estimates & Forecasts by Drug Class 2020-2030 (USD Billion)
  • 5.4. Organ Transplant Rejection Medication Market, Sub Segment Analysis
    • 5.4.1. Antibodies
    • 5.4.2. Antimetabolites
    • 5.4.3. Calcineurin Inhibitors
    • 5.4.4. mTOR Inhibitors
    • 5.4.5. Steroids

Chapter 6. Global Organ Transplant Rejection Medication Market, by Transplant Type

  • 6.1. Market Snapshot
  • 6.2. Global Organ Transplant Rejection Medication Market by Transplant Type, Performance - Potential Analysis
  • 6.3. Global Organ Transplant Rejection Medication Market Estimates & Forecasts by Transplant Type 2020-2030 (USD Billion)
  • 6.4. Organ Transplant Rejection Medication Market, Sub Segment Analysis
    • 6.4.1. Kidney
    • 6.4.2. Liver
    • 6.4.3. Heart
    • 6.4.4. Lung
    • 6.4.5. Pancreas
    • 6.4.6. Others

Chapter 7. Global Organ Transplant Rejection Medication Market, by Distribution Channel

  • 7.1. Market Snapshot
  • 7.2. Global Organ Transplant Rejection Medication Market by Distribution Channel, Performance - Potential Analysis
  • 7.3. Global Organ Transplant Rejection Medication Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
  • 7.4. Organ Transplant Rejection Medication Market, Sub Segment Analysis
    • 7.4.1. Hospitals Pharmacies
    • 7.4.2. Retail Pharmacies
    • 7.4.3. Online Pharmacies

Chapter 8. Global Organ Transplant Rejection Medication Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Organ Transplant Rejection Medication Market, Regional Market Snapshot
  • 8.4. North America Organ Transplant Rejection Medication Market
    • 8.4.1. U.S. Organ Transplant Rejection Medication Market
      • 8.4.1.1. Drug Class breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Transplant Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. Distribution Channel breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Organ Transplant Rejection Medication Market
  • 8.5. Europe Organ Transplant Rejection Medication Market Snapshot
    • 8.5.1. U.K. Organ Transplant Rejection Medication Market
    • 8.5.2. Germany Organ Transplant Rejection Medication Market
    • 8.5.3. France Organ Transplant Rejection Medication Market
    • 8.5.4. Spain Organ Transplant Rejection Medication Market
    • 8.5.5. Italy Organ Transplant Rejection Medication Market
    • 8.5.6. Rest of Europe Organ Transplant Rejection Medication Market
  • 8.6. Asia-Pacific Organ Transplant Rejection Medication Market Snapshot
    • 8.6.1. China Organ Transplant Rejection Medication Market
    • 8.6.2. India Organ Transplant Rejection Medication Market
    • 8.6.3. Japan Organ Transplant Rejection Medication Market
    • 8.6.4. Australia Organ Transplant Rejection Medication Market
    • 8.6.5. South Korea Organ Transplant Rejection Medication Market
    • 8.6.6. Rest of Asia Pacific Organ Transplant Rejection Medication Market
  • 8.7. Latin America Organ Transplant Rejection Medication Market Snapshot
    • 8.7.1. Brazil Organ Transplant Rejection Medication Market
    • 8.7.2. Mexico Organ Transplant Rejection Medication Market
  • 8.8. Middle East & Africa Organ Transplant Rejection Medication Market
    • 8.8.1. Saudi Arabia Organ Transplant Rejection Medication Market
    • 8.8.2. South Africa Organ Transplant Rejection Medication Market
    • 8.8.3. Rest of Middle East & Africa Organ Transplant Rejection Medication Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Pfizer, Inc.
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Astellas Pharma Global Development, Inc.
    • 9.3.3. F, Hoffmann-La Roche Ltd.
    • 9.3.4. Bristol-Myers Squibb Company
    • 9.3.5. GlaxoSmithKline plc.
    • 9.3.6. AbbVie Inc.
    • 9.3.7. Viatris, Inc.
    • 9.3.8. Hikma Pharmaceuticals plc.
    • 9.3.9. Teva Pharmaceutical Industries Ltd,
    • 9.3.10. Cadila Healthcare Limited

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption